KMT2C and breast cancer: In addition to TP53 and PTEN mutations, activating mutations in PIK3CA are a common occurrence in breast cancers and MLL3 has been identified as a PIK3CA‐cooperating gene using CRISPR/Cas9 genome editing [16].